Deciphera Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US24344T1016
BU SEMBOL ARTIK AKTİF DEĞİL

SecurityDCPH / Deciphera Pharmaceuticals, Inc.
InstitutionCutler Group LP
Latest Disclosed Ownership300 shares
Latest Disclosed Value $ 4
Cutler Group LP ownership in DCPH / Deciphera Pharmaceuticals, Inc.

On April 19, 2024 - Cutler Group LP filed a 13F-HR form disclosing ownership of 300 shares of Deciphera Pharmaceuticals, Inc. (US:DCPH) valued at $4,719 USD as of March 31, 2024. The entity filed a previous 13F-HR on January 18, 2024 disclosing 500 shares of Deciphera Pharmaceuticals, Inc.. The current value of the position is $7,677 USD.

Cutler Group LP has a history of taking positions in derivatives of the underlying security (DCPH) in the form of stock options. The firm currently holds call options representing 500 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DCPH / Deciphera Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-04-19 2024-03-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 300 -200 -40.00 0 0.0013
2024-01-18 2023-12-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 500 -100 -16.67 0 0.0007
2023-11-07 2023-09-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 600 0 0.00 0 0.0007
2023-07-18 2023-06-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 600 0 0.00 0 0.0011
2023-05-01 2023-03-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 600 -200 -25.00 0 0.0009
2023-02-07 2022-12-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 800 300 60.00 0 -100.00 0.0011
2022-10-25 2022-09-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 500 -1,300 -72.22 9 -60.87 0.0006
2022-08-04 2022-06-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 1,800 -1,500 -45.45 23 -23.33 0.0016
2022-04-14 2022-03-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 3,300 -1,100 -25.00 30 -28.57 0.0016
2022-01-18 2021-12-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 4,400 -300 -6.38 42 -73.58 0.0018
2021-10-26 2021-09-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 4,700 -3,050 -39.35 159 -43.82 0.0071
2021-07-19 2021-06-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 7,750 2,451 46.25 283 19.41 0.0132
2021-04-26 2021-03-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 5,299 3,600 211.89 237 146.88 0.0117
2021-01-21 2020-12-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 1,699 -1,100 -39.30 96 -32.87 0.0046
2020-10-27 2020-09-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 2,799 -900 -24.33 143 -35.00 0.0088
2020-07-22 2020-06-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 3,699 -218 -5.57 220 36.65 0.0145
2020-05-07 2020-03-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 3,917 -27,744 -87.63 161 -91.83 0.0083
2020-02-06 2019-12-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 31,661 31,461 15,730.50 1,970 32,733.33 0.1206
2019-10-28 2019-09-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 200 200 6 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-04-19 2024-03-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 500 150.00 0 n/a n/a n/a
2024-01-18 2023-12-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 200 0 n/a n/a n/a
2023-05-01 2023-03-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 0 -100.00 0 n/a n/a n/a
2023-02-07 2022-12-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 4,000 0.00 0 -100.00 n/a n/a n/a
2022-10-25 2022-09-30 13F DECIPHERA PHARMACEUTICALS IN Call Call 4,000 0.00 9 50.00 n/a n/a n/a
2022-08-04 2022-06-30 13F DECIPHERA PHARMACEUTICALS IN Call Call 4,000 6 n/a n/a n/a
2022-04-14 2022-03-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 0 -100.00 0 n/a n/a n/a
2022-01-18 2021-12-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 1,100 -45.00 0 -100.00 n/a n/a n/a
2021-10-26 2021-09-30 13F DECIPHERA PHARMACEUTICALS IN Call Call 2,000 -88.10 2 -77.78 n/a n/a n/a
2021-07-19 2021-06-30 13F DECIPHERA PHARMACEUTICALS IN Call Call 16,800 22.63 9 -86.36 n/a n/a n/a
2021-04-26 2021-03-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 13,700 34.31 66 50.00 n/a n/a n/a
2021-01-21 2020-12-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 10,200 78.95 44 214.29 n/a n/a n/a
2020-10-27 2020-09-30 13F DECIPHERA PHARMACEUTICALS IN Call Call 5,700 32.56 14 -66.67 n/a n/a n/a
2020-07-22 2020-06-30 13F DECIPHERA PHARMACEUTICALS IN Call Call 4,300 -75.00 42 44.83 n/a n/a n/a
2020-05-07 2020-03-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 17,200 -74.25 29 -94.43 n/a n/a n/a
2020-02-06 2019-12-31 13F DECIPHERA PHARMACEUTICALS IN Call Call 66,800 521 n/a n/a n/a
2019-10-28 2019-09-30 13F DECIPHERA PHARMACEUTICALS IN Call Call 0 -100.00 0 n/a n/a n/a
2019-08-09 2019-06-30 13F DECIPHERA PHARMACEUTICALS IN Call Call 200 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-18 2021-12-31 13F DECIPHERA PHARMACEUTICALS IN Put Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-26 2021-09-30 13F DECIPHERA PHARMACEUTICALS IN Put Put 2,500 -80.00 127 -31.72 n/a n/a n/a
2021-07-19 2021-06-30 13F DECIPHERA PHARMACEUTICALS IN Put Put 12,500 25.00 186 23.18 n/a n/a n/a
2021-04-26 2021-03-31 13F DECIPHERA PHARMACEUTICALS IN Put Put 10,000 17.65 151 81.93 n/a n/a n/a
2021-01-21 2020-12-31 13F DECIPHERA PHARMACEUTICALS IN Put Put 8,500 21.43 83 -19.42 n/a n/a n/a
2020-10-27 2020-09-30 13F DECIPHERA PHARMACEUTICALS IN Put Put 7,000 -6.67 103 18.39 n/a n/a n/a
2020-07-22 2020-06-30 13F DECIPHERA PHARMACEUTICALS IN Put Put 7,500 0.00 87 -50.57 n/a n/a n/a
2020-05-07 2020-03-31 13F DECIPHERA PHARMACEUTICALS IN Put Put 7,500 -82.72 176 -11.56 n/a n/a n/a
2020-02-06 2019-12-31 13F DECIPHERA PHARMACEUTICALS IN Put Put 43,400 4,240.00 199 n/a n/a n/a
2019-10-28 2019-09-30 13F DECIPHERA PHARMACEUTICALS IN Put Put 1,000 -47.37 0 -100.00 n/a n/a n/a
2019-08-09 2019-06-30 13F DECIPHERA PHARMACEUTICALS IN Put Put 1,900 6 n/a n/a n/a
2019-05-10 2019-03-31 13F DECIPHERA PHARMACEUTICALS IN Put Put 0 -100.00 0 n/a n/a n/a
2019-02-05 2018-12-31 13F DECIPHERA PHARMACEUTICALS IN Put Put 200 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.